and increase in oxidative stress by free radicals are being explored as potential pathways for cigarette smoking mediated cardiovascular dysfunction. (Kugiyama et al., 1996) In addition, general mechanisms have been proposed for smoker's susceptibility to pathogenic or opportunistic bacteria. The mechanisms include (i) tobacco-induced physiological and structural changes in human smokers, (ii) tobacco-induced increase in bacterial virulence and (iii) tobacco-induced dysregulation of immune function. (Wang and Scott 2005) These studies bring insight to mechanisms in tobacco induced physiological changes by hindering the mucociliary clearance and the dysregulation of immune system. Overall, the mechanisms behind tobacco's ability to cause disease needs to be further study so that a better perspective of disease progression can be known.
Periodontal disease is chronic progressive disease that affects an estimated 22%
of US adults with mild forms of the disease and 13% with moderate to severe 
MATERIALS AND METHODS

Materials
Ultra-pure LPS from Escherichia coli 0111:B4 were purchased from Invivogen.
(−)-Nicotine was purchased from Sigma-Aldrich Co., St. Louis, MO. α-Bungarotoxin was purchased from Tocris Bioscience. α7nAChR antibody (H-302), α7nAChR siRNA (h) and scrambled control siRNA were purchased from Santa Cruz Biotechnology, Inc, Dallas, Tx. All other Abs were obtained from Cell Signaling Technology. Cytokine ELISA kits were purchased from eBioscience.
Cell preparation
PBMCs were obtained from the venous blood of healthy donors as per protocols approved by the University of Louisville, Institutional Review Board, and Human Subjects Protection Program. Monocytes were isolated by negative selection using the human monocyte isolation kit II from Miltenyi Biotec. The purity of monocytes was routinely >90%, as determined by flow cytometry using an FITC-labeled anti-CD14 Ab.
Monocyte cells were cultured in RPMI 1640 medium supplemented with 10% FBS, 1 mM sodium pyruvate, 2 mM L-glutamine (Wang, Garcia et al. 2008 ).
Gelatin zymography
The conditioned growth media were mixed with 4x non-reducing sample buffer and resolved at 120 V in 7.5 % sodium dodecylsulphate-polyacrylamide gel electrophoresis (SDS-PAGE) gels copolymerized with 1 mg/ml gelatin. The gels were then washed with 2.5% Triton X-100 for three 20 min cycles. The gels were then incubated in fresh zymogram buffer containing 50 mM Tris (pH 7.5), 3 mM NaN 3 , 5 mM CaCl 2 and 1 μM ZnCl 2 at 37°C overnight and were stained with Coomassie blue to visualize the proteolytic bands.
Transfection, cytokine detection, and Western blot
Transfection of human monocytes were carried out by electroporation using a 4D
Nucleofector device (Lonza) according to the manufacturer's protocols. Briefly, purified 1 × 10 7 monocytes were resuspended in 100 μl Nucleofector solution (Human Monocytes Nucleofector kit; Lonza) and 6 μg siRNA duplexes for each α7nAChR nicotinic receptor and scrambled control siRNA duplex. Immediately after electroporation, 1 ml pre warmed RPMI growth media containing 10% FBS were added to cells that were then transferred into 96 well plate. At 48 h post transfection, cells were exposed to LPS (1 μg/ml) with or without Nicotine. Cell lysates were prepared using RIPA buffer. For siRNA studies, transfected cells were stimulated with LPS (1 μg/ml) and Nicotine (100 ng/ml), 3 d post transfection, and cell-free supernatants were assayed for cytokine levels by ELISA (eBioscience) at 18 h.
Western blot
An equal amount of total protein from primary monocyte resolved in 10% SDS-PAGE gels at 120 V. The proteins on the gels were transferred to nitrocellulose membrane at 0.3 A for 90 min using transfer buffer (25 mM Tris-HCl (pH 8.3),
192 mM glycine and 10% methanol). The membranes were then incubated in 3% milk in tris-buffered solution with 0.1% Tween-20 (TBST, pH 7.4) for 1 h to block nonspecific binding. The membranes were then incubated with primary antibodies at 4°C overnight.
Antibodies used in this study were anti-α7nAChR, anti-GSK3b, anti-MMP-9, and β-actin. The membranes were then washed three times with TBST and incubated with horseradish peroxidase-conjugated secondary antibodies for 1 h at room temperature.
Chemiluminescence was detected by an ECL-Plus kit (Thermo Scientific, Pittsburgh, PA) and the protein bands were visualized using ImageQuant LAS 4010 (GE Heathcare, Pittsburgh, PA). Densitometric analysis of protein band intensity was performed using the GelQuantNET software (biochemlabsolutions.com) and normalized with the loading control.
Statistical analysis
All data are presented as means ± SEM. Comparison between groups was made using one-way ANOVA with the Fisher multiple comparison test. A probability value of p < 0.05 was considered statistically significant. All cell culture experiments were performed in triplicate on at least three separate occasions.
RESULTS
Nicotine Suppresses LPS induced secretion of MMP9
Primary monocytes were stimulated with LPS (1 µg/ml) and Nicotine (100 ng/ml) and MMP9 secretion were studied by ELISA. As shown in figure 3 . LPS leads to significant increase in MMP9 secretion which is blocked by 100 ng/ml nicotine. Nicotine alon had no significant effect on MMP9 secretion as compared to vehicle. 
Nicotine suppresses MMP9 secretion α7nAChR dependent manner
To understand the role of α7nAChR in monocyte secretion of MMP9, the cells were pretreated with α-bungarotoxin (BTX). α-bungarotoxin known to bind irreversibly to α7nAChR thereby preventing nicotine to bind to it. As shown in figure 4 , BTX had no effect on LPS induced secretion of MMP9 as studied by ELISA but when LPS was added to nicotine treated monocytes, nicotine failed to block the effect of LPS on MMP9 secretion suggesting the role of α7nAChR in secretion of MMP9. Furthermore, to establish the role of α7nAChR in secretion of MMP9 in monocytic cells, we used knockdown approach using siRNA techniques. First, we established that we could significantly knock down the expression of α7nAChR using western blot techniques ( Figure 5 ). Thereafter, we studied the effect of nicotine on LPS induced secretion of MMP9 in monocytic cells. In the same siRNA treated cells nicotine has lost it ability to block the LPS induced secretion of MMP9 in the monocytic cells as quantified by ELISA ( Figure  6 ). 
Nicotine blocks the LPS induced secretion of MMP9 as studied by zymogram
We studied the effect of nicotine on LPS induced secretion of MMP9 using 0.1% gelatin gel. As evident from the figure 7, the nicotine lead to decrease in active MMP9 activity in LPS induced MMP9 secretion in the scrambled control siRNA treated monocytic cells but the blocking effect of nicotine on LPS induced secretion of active MMP9 was significantly reduced in the α7nAChR siRNA treated monocytic cells. Nicotine ability to engage the anti-inflammatory pathway and interfere with matrix metalloproteinase is novel as well. The anti-inflammatory pathway has been studied in its role in other inflammatory cytokines but to perhaps matrix metalloproteinase 9 into its mechanism of action is novel because matrix metalloproteinase is a proteinase and not a cytokine or chemokine. Matrix metalloproteinases have the ability to structurally change the extracellular matrix to allow for the availablilty of cytokines and chemokines which further express the inflammatory response that it is novel that nicotine could possibly be interferning with the inflammatory response further upstream by limiting MMP secretion so chemokines and cytokines available which leads to the further suppression of cytokines. A reduction in pro-inflammmatory cytokines promotes survival of periodontal pathogens that encourage disease progression. Therefore, a decrease in secretion of matrix metalloproteinase by a primary monocyte exposed to nicotine could further inhibit the inflammatory response by restricting chemotaxis. In conclusion, the novel finding of nicotine altering the secretion of matrix metalloproteinase will add to current research and be an addition to future research.
Limitations on the proposed model could be that LPS E. coli is a bacteria pathogen that is not specifically found in large amounts in the periodontal tissues. When applying the model to periodontal disease it may be applicable to involve periodontal pathogens. 
